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After it was demonstrated that 1H magnetic resonance 
spectroscopy (MRS) can noninvasively distinguish intra-
myocellular lipids (IMCLs) from extramyocellular lipids 
(EMCLs) (1, 2), associations were reported between soleus 
(SOL) IMCL accumulation and insulin resistance indepen-
dent of fat mass (3–5). Given that skeletal muscle repre-
sents the primary site for postprandial glucose disposal (6), 
these findings were of considerable physiological interest. 
Furthermore, these data strongly supported the link 
between ectopic fat accumulation and insulin resistance 
(7, 8). Although it soon became clear that triglycerides them-
selves were unlikely to be involved in causing insulin resis-
tance, intramuscular triglyceride content does seem to 
correlate with insulin resistance in some states (5, 9–12). 
One particularly striking and surprising exception was re-
ported in athletes, in which histological studies suggested 
that neutral lipid accumulation was a feature of skeletal 
muscle in insulin-sensitive, endurance-trained athletes 
(13, 14), and this finding has led to the now widely cited 
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notion of an “athlete’s paradox” (13). This concept is con-
sistent with the idea that triglyceride content itself is not 
casually involved in insulin resistance and has prompted 
several efforts to identify the lipid intermediates responsi-
ble for causing insulin resistance or preserving the insulin 
sensitivity of athletes.
Saturated fat has been implicated in the pathogenesis of 
metabolic disease (15, 16), and we have recently described 
and validated (using IMCL/EMCL-simulated phantoms of 
known composition) a 1H MRS method that provides an in 
vivo compositional marker of IMCLs that primarily reflects 
the degree of saturation of the FA chains within triglycer-
ides (17). This marker, which we call the IMCL saturation 
index (CH2:CH3), utilizes good-quality spectra acquired at 
3T with a short echo time and compares the CH2 resonance 
located at 1.3 ppm (which is influenced by both concentra-
tion and composition) with that of the CH3 resonance at 0.9 
ppm (which is independent of triglyceride composition); 
this is illustrated in Fig. 1. Figure 1 also shows that using a 
concentration of hydrogen that resonates at 1.3 ppm (CH2) 
to represent the concentration of lipids without knowing 
the underlying composition, as has been the practice in vir-
tually all published 1H MRS studies of IMCLs so far, con-
founds the contributions of both the concentration of lipids 
and their composition. This can potentially lead to a signifi-
cant error in estimating the concentration: the composition 
would contribute as much as 50% to the observed signal 
(equivalent to a 100% theoretical increase in the signal) if 
the pool were stearic acid instead of linoleic acid. There-
fore, we used the IMCL CH3 peak at 0.9 ppm to estimate the 
total concentration of IMCLs, as this is independent of 
the degree of saturation of the FA chains within triglycer-
ides (i.e., composition). We call this the composition-
independent IMCL concentration estimate to distinguish it 
from the conventional estimate using CH2.
Lipodystrophy is a rare cause of severe insulin resistance 
and is typically characterized by prominent ectopic fat ac-
cumulation due to both the reduction in adipocyte lipid 
storage capacity and the associated hyperphagia induced 
by leptin deficiency. To ascertain whether IMCL composi-
tion is altered in lipodystrophic (LD) subjects and if such 
changes in lipid composition might help to elucidate the 
athlete’s paradox, we determined the compositional satu-
ration index (CH2:CH3 ratio) and composition-independent 
concentration (from CH3) of IMCLs in the SOL and tibialis 
anterior (TA) muscles of female insulin-resistant LD sub-
jects as well as age- and gender-matched athletes and non-
athlete controls.
MATERIALS AND METHODS
Participants
Sixteen female subjects with lipodystrophy were identified as 
part of a long-standing study of human insulin-resistant syn-
dromes, while age- and gender-matched controls (n = 41) and 
athletes (n = 14) were recruited by advertisement. SOL IMCL data 
from five of the subjects were included in a previously published 
study (18). Control and athlete exclusion criteria included cur-
rent smoking; drug or alcohol addiction; any current or past med-
ical disorder or medications that could affect measurements, 
including supplements such as creatine; and standard MRI con-
traindications. Controls were recruited who exercised less than 
three times per week for 1 h each time, while the athletes, some of 
whom competed in international events, were part of a running 
club and regularly ran distances between 10 and 40 km. Subjects 
with lipodystrophy were recruited if they could perform an over-
night fast without insulin or a rapid-acting insulin analogue. The 
Fig. 1. The ratio of CH2:CH3 is influenced primarily 
by the degree of saturation of the FAs within triglycer-
ides. This figure shows the principle of the CH2:CH3 
ratio as a compositional saturation index of IMCLs. A: 
In this example, the palmitoleic acid component of 
triglyceride has a theoretical ratio of CH2 (at 1.3 ppm) 
to CH3 (at 0.9 ppm) of 16/3 = 5.3, which is lower than 
the equivalent ratio of palmitic acid (8.0). This is due 
not only to the desaturation of two CH2 groups but 
also to the alteration in the chemical environment of 
the neighboring CH2 groups. For FA chains with an 
equal number of double bonds, the CH2:CH3 ratio will 
also be scaled by chain length, although this will have 
a proportionally smaller effect (17). B: Theoretical 
CH2:CH3 values for stearic, oleic, and linoleic FAs and 
approximate practical values, which are systematically 
shifted with respect to the theoretical values, as dis-
cussed in Thankamony et al. (17). Part of this figure 
has been reproduced from Thankamony et al. (17), 
which is licensed under a Creative Commons Attribu-
tion 4.0 International License.
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studies relating to lipodystrophy were approved by the NHS Re-
search Ethics Committee, and the healthy volunteer studies were 
approved by the East of England Cambridge Central Ethics Com-
mittee. Studies were conducted in accordance with the Declara-
tion of Helsinki, and all participants provided written informed 
consent.
Protocol
Volunteers were instructed to follow normal dietary habits 
for 3 days before arriving at the National Institute for Health 
Research (NIHR)/Wellcome Trust Clinical Research Facility. 
Participants provided fasting blood samples and were given a 
light breakfast of either toast or cereal immediately prior to 1H 
MRS. Athletes and controls were instructed to refrain from vig-
orous exercise for at least 24 and 19 h, respectively, prior to 1H 
MRS.
HOMA-IR was calculated as fasting insulin (pmol/l) × fasting 
glucose (U/ml)/22.5. Body composition was assessed by dual-
energy X-ray absorptiometry (Lunar Prodigy enCORE version 
12.5 for controls and Lunar iDXA enCORE version 16 for ath-
letes; GE Healthcare, Madison, WI).
1H MRS
1H MRS studies were performed on a 3T scanner (Siemens; 
Erlangen, Germany) using the point-resolved spectroscopy se-
quence with a short echo time of 35 ms. A water-suppressed 1H 
spectrum was acquired from a voxel with a cube length of 1.3 cm 
positioned to avoid visible fat on T1-weighted images within TA 
and SOL using a 5 s repetition time and 64 averages (4 averages 
for the nonwater-suppressed spectrum). Data were analyzed in 
jMRUI (19, 20) and fitted with the AMARES (21) algorithm us-
ing identical prior-knowledge parameters: Gaussian line shapes 
(except water: Lorentzian), soft constraints on EMCL/IMCL CH2 
frequencies and line widths, CH3 resonant frequencies and line 
widths determined from known and inferred prior knowledge 
relative to the CH2 resonance (22), and with all amplitudes esti-
mated. Because the CH3 resonance is small and may be subject to 
spectral overlap, the results were later checked for robustness by 
reanalyzing the data using different fitting parameters, as out-
lined in supplemental Table S1. IMCL CH2 and CH3 are quanti-
fied relative to the methyl group of creatine plus phosphocreatine 
at 3.0 ppm. Because this resonance exhibits different line-shape 
characteristics in the TA and SOL muscles (23), comparable 
quantification between muscles using a nominal concentration of 
muscle creatine is not valid; instead, a scaling factor of creatine to 
water for each muscle was established from a subset of partici-
pants who had nonwater-suppressed data sets, yielding a calcu-
lated water signal. Absolute composition-independent IMCL 
concentrations in mmol/kg muscle wet weight were calculated 
from the compositionally invariant CH3 IMCL resonance, with 
standard assumptions regarding muscle water content and correc-
tion for T2 relaxation effects, J coupling, and proton density as 
outlined below.
Absolute IMCL concentrations in mmol/kg muscle wet weight 
were calculated using the CH3 IMCL resonance (which is compo-
sitionally invariant) using the following equation:
[ ] ( ) [ ]−= o IMCL CH3 o water calcIMCL S S . water
where So is the corrected signal intensity of the resonance, water-
calc is the calculated water signal from the internal standard (cre-
atine and phosphocreatine), and [water] is the concentration of 
water in skeletal muscle [calculated using a pure water concen-
tration of 55,342 mmol/l and assuming a relative tissue water 
content in human skeletal muscle of 0.81 (kg/kg) and tissue den-
sity of 1.05 g/ml (24)]. Because the IMCL CH3 resonance is sub-
ject to J-coupling effects and has an unknown T2 relaxation time, 
we utilized the theoretical-to-measured IMCL CH3:CH2 ratio that 
would take into effect both J-coupling and T2 effects at this echo 
time as well as any bias of constrained fitting prior knowledge of 
the CH3 resonance.
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where S is the uncorrected signal intensity of the resonance. 
(GTM CH3:CH2) = 1.1966 and is the gradient of the line of best fit 
through the origin of the graph of theoretical-to-measured 
CH3:CH2 in vitro in IMCL- and EMCL-simulated phantoms us-
ing the point-resolved spectroscopy sequence at 3T with an 
echo time of 35 ms with the same fitting (17), assuming that 
J-coupling and T2 relaxation effects would be similar in vivo. 
(T2corr CH2/water) is the correction factor for T2 effects of CH2 and 
water that was calculated using accepted T2 values at 3T for 
each muscle (25), and (nwater:IMCL CH3) is the correction for pro-
ton density.
The IMCL saturation index (CH2:CH3) was calculated as 
IMCL CH2:CH3, and the IMCL saturation index adjusted for 
quantity (CH2:CH3adj) = CH2 – (mCH3 + c), where m and c are the 
gradient and intercept, respectively, of the regression line 
through the control data points of CH2 versus CH3. Investigators 
were blind to the insulin-resistance status of the participants dur-
ing 1H MRS analysis.
Assessment of VO2max
Participants underwent continuous incremental exercise test-
ing to an 85% age-predicted maximum heart rate (controls) or 
volitional exhaustion (athletes) on a Trackmaster TMX425 tread-
mill (Med-Electronics, Beltsville, MD). LD subjects did not per-
form an exercise test. Oxygen consumption was measured using a 
spiroergometer (Medical Graphics UK Ltd, Gloucester, UK) and 
BreezeSuite gas-exchange software. For the control participants, a 
standard incremental protocol was performed (26), whereas the 
athletes undertook a protocol that began with a 10 min warm-up 
period at each participant’s preferred warm-up running speed, 
after which the test was initiated at 9 km/h and increased steadily 
(0.74 km/h/min), with a ramp at 5 min (increasing 0.5% every 15 s) 
until exhaustion or a plateau in VO2 was apparent. VO2max was 
calculated in the control participants by extrapolating the sub-
maximal heart rate – VO2 relationship to the age-predicted maxi-
mum heart rate (27).
Statistics
All statistics were performed in SPSS Statistics 24 (IBM, 
Armonk, NY) with significance set at P < 0.05. Normality was 
assessed by the Shapiro-Wilk test, and nonnormally distributed 
data were log-transformed prior to statistical testing. ANOVA 
with Games-Howell post hoc analysis was used to compare means 
between groups, and Pearson’s correlation coefficient was used 
for analyzing associations. Due to the nonnormality of ln(HOMA-IR), 
IMCL associations with HOMA-IR were assessed by Spearman’s 
rank correlation coefficient. Data are presented as means ± 
SEMs.
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RESULTS
Participants
Of the insulin-resistant subjects with lipodystrophy, 13 
had partial forms [8 subjects with familial partial lipodys-
trophy (FPLD) type 2 due to LMNA mutations, 5 subjects 
with FPLD3 due to PPARG mutations), and 3 had general-
ized lipodystrophy [2 subjects with acquired generalized 
lipodystrophy (AGLD) and 1 due to mutations in the 
PCYT1A gene (28)]. Of the LD subjects, two were taking no 
medication at all, eight were prescribed metformin, three 
were taking statins, five were taking fibrates, and five were 
taking long-acting insulin analogues. The age- and gender-
matched controls had a wide BMI range (19.6–35.6 kg/m2) 
and HOMA-IR (0.3–4.9). As a group, insulin and HOMA-
IR were significantly higher in the LD subjects and lower in 
the athletes (Table 1) compared with controls, as expected. 
Fat mass and percentage body fat were similar between LD 
subjects and athletes, which were both lower compared 
with controls (Table 1). Serum triglycerides were higher 
and HDL-cholesterol concentrations were lower in the LD 
subjects (Table 1) compared with either controls or ath-
letes. EMCLs were absent in the two subjects with AGLD 
(Fig. 2), but those with partial forms of lipodystrophy had 
an EMCL concentration such that overall LD subjects’ 
EMCL concentration was similar to both controls and ath-
letes (Table 1).
1H MRS analysis of IMCL concentration
In the SOL muscle, IMCL concentrations derived from 
the IMCL CH3 peak (0.9 ppm) (composition-independent 
IMCL concentrations) were not significantly increased 
(P = 0.477) in the LD subjects compared with controls 
but were higher compared with the lean athletes (P = 
0.003) (Fig. 3A). In the more glycolytic TA muscle, com-
position-independent IMCL concentrations were similar 
in all three groups (Fig. 3B). We also observed linear in-
verse correlations of VO2max and the IMCL concentration 
in the subset of controls who underwent VO2max testing 
and athletes together (Fig. 3C, D). SOL IMCL concentra-
tion was significantly lower in the athletes compared with 
the controls (P = 0.004; Fig. 3A), and this remained sig-
nificant (P = 0.025) compared with a subset of the con-
trols matched for percentage body fat (controls: body 
fat = 21.5 ± 2.3%, n = 10; athletes: 21.1 ± 1.8%, n = 14; see 
supplemental Fig. S1).
The conventional estimate of IMCL concentration using 
the CH2 resonance uncorrected for composition, CH2/wa-
ter, showed similar trends to the composition-independent 
estimate using the CH3 peak with the exception that the 
LD subjects’ SOL IMCL CH2 was significantly increased 
compared with controls (Table 1). This could be regarded 
as an artifact of the effects of compositional differences, 
which we consider next.
1H MRS analysis of IMCL composition
IMCLs had a significantly higher saturation index 
(CH2:CH3) in both muscles of the LD subjects compared 
with controls (SOL P = 0.008; TA P = 0.024) but not ath-
letes (Fig. 4A, B). In the control group, smaller IMCL pools 
were associated with a higher saturation index, as shown by 
the linear regression line (dotted line in Fig. 3E, F) having 
a gradient (CH2/CH3) that was less than the mean 
CH2:CH3 (e.g., gradient SOL = 6.7 vs. mean CH2:CH3 = 8.8; 
TABLE 1. Participant characteristics and conventional muscle lipid estimates
LD Females  
(n = 16)
Female Controls 
(n = 41)
Female Athletes  
(n = 14)
P 
ANOVA LD—Controls LD—Athletes Controls—Athletes
Participant characteristics
 Age (years) 38.9 ± 3.9 35.5 ± 2.0 36.5 ± 2.9 0.694
 BMI (kg/m2) 24.2 ± 0.7 24.4 ± 0.6 20.3 ± 0.6 <0.001 0.999 0.001 <0.001
 Mass (kg) 66.1 ± 2.8 65.2 ± 2.3 54.6 ± 1.3 0.013 0.916 0.006 0.001
 Fat mass (kg) 10.6 ± 1.4 23.1 ± 1.6 11.6 ± 1.1 <0.001 0.001 0.631 <0.001
 Fat-free mass (kg) 55.4 ± 1.7 42.1 ± 0.9 43.0 ± 1.2 <0.001 <0.001 <0.001 0.705
 Body fat (%) 16.1 ± 1.7 34.2 ± 1.2 21.1 ± 1.8 <0.001 <0.001 0.129 <0.001
 Triglycerides (mmol/l) 3.54 ± 0.67 0.92 ± 0.07a 0.84 ± 0.08 <0.001 <0.001 <0.001 0.920
 HDL-cholesterol (mmol/l) 0.97 ± 0.71 1.64 ± 0.06a 2.20 ± 0.12 <0.001 <0.001 <0.001 0.001
 Glucose (mmol/l) 6.00 ± 0.58 4.56 ± 0.06a 4.46 ± 0.13 <0.001 0.063 0.002 0.764
 Insulin (pmol/l)b 145.6 ± 22.0 38.6 ± 4.2a 22.6 ± 4.7 <0.001 <0.001 <0.001 0.025
 HOMA-IR 5.53 ± 1.0 1.14 ± 0.13a 0.66 ± 0.15 <0.001 <0.001 <0.001 0.025
 HbA1c (%) 6.6 ± 0.4c ND 5.3 ± 0.1 ND 0.008
 VO2max (ml/kg/min) ND 36.1 ± 1.5
d 46.9 ± 1.4 ND <0.001
Conventional estimatese
 SOL IMCLs 1.90 ± 0.21 1.22 ± 0.07 0.79 ± 0.10 <0.001 0.027 <0.001 0.007
 TA IMCLs 0.89 ± 0.16f 0.61 ± 0.04 0.45 ± 0.04 0.035 0.562 0.115 0.078
 SOL EMCLs 2.05 ± 0.34 2.22 ± 0.19 1.81 ± 0.20 0.493
 TA EMCLs 1.43 ± 0.28f 2.30 ± 0.19 1.24 ± 0.15 0.002 0.163 0.785 0.005
Data are presented as mean ± SEM unless otherwise stated. Nonnormally distributed variables were log-transformed prior to performing ANOVA 
and Games-Howell post hoc analysis; bold P values are statistically significant.
an = 38.
b To convert to U/ml divide by 6.945.
cn = 13.
dn = 24.
e Expressed as methylene protons resonating at 1.3 ppm quantified as a percentage of the uncorrected calculated water resonance.
fn = 12.
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gradient TA = 4.2 vs. mean CH2:CH3 = 6.0). This phe-
nomenon seemed to be independent of insulin sensitiv-
ity in the controls (Table 2; there was no relation of 
HOMA-IR with IMCL concentration). To generate a 
pathophysiologically meaningful measure of composi-
tion that is independent of IMCL quantity, the vertical 
(CH2) deviation from this regression line was measured 
and taken as a marker of the saturation of the pool that is 
adjusted for quantity, which we term the adjusted satura-
tion index (CH2:CH3adj). This adjusted compositional 
marker was significantly higher in LD subjects compared 
with athletes (SOL P = 0.001; TA P = 0.046) and controls 
(SOL P = 0.003), with a tendency in the TA that falls just 
short of conventional statistical significance (P = 0.06) 
(Fig. 4C, D).
Unlike the uncorrected measure of composition, this 
adjusted composition also had a significant relation to 
VO2max (Fig. 4E, F) within the control subset alone, athletes 
alone (SOL), and control and athletes combined, such 
that fitter individuals had less saturated IMCLs for the 
same absolute quantity of IMCLs. VO2max was significantly 
correlated with HOMA-IR in the control subset (r = 0.59, 
P = 0.003, n = 23) and in controls and athletes together 
(r = 0.53, P = 0.001, n = 37). Figure 4G and H show the 
relation of the adjusted composition to HOMA-IR. Table 2 
shows relations of IMCL concentration and composition 
with insulin sensitivity. The saturation index was higher in 
the SOL muscle compared with the TA in all three groups. 
This was still the case in the two EMCL-deficient AGLD 
subjects (subject 1: SOL CH2:CH3 = 9.5 and TA CH2:CH3 = 
6.3; subject 2: SOL CH2:CH3 = 11.2 and TA CH2:CH3 = 
7.1). The IMCL relations with HOMA-IR were robust to 
differing fitting parameters, as shown in supplemental 
Table S1.
DISCUSSION
Using a recently validated 1H MRS method we compared 
a compositional saturation index (CH2:CH3 ratio) of 
IMCLs in the SOL and TA muscles of female insulin-resistant 
LD subjects with that of age- and gender-matched athletes 
and healthy controls and showed it to be significantly 
higher in both muscles compared with controls but not 
athletes. The finding that smaller IMCL pools in the con-
trol group had a relatively higher saturation index than 
larger pools irrespective of insulin sensitivity could possibly 
explain why the athletes studied here, who had small IMCL 
pools, had a composition that was statistically similar to LD 
subjects. This observed concentration-composition rela-
tionship seems physiologically plausible given that more 
unsaturated and shorter-chain FAs are preferentially mobi-
lized (17). A similar trend was also visible in a previous data 
set from both TA and SOL muscles of 19 healthy males af-
ter an 8 h fast (17). We hypothesize that a person may 
“move” along a line such as this while performing daily ac-
tivities and that a measurement of deviation from this rela-
tionship may therefore be a more sensitive and specific 
measure of muscle metabolic physiology or pathophysiol-
ogy. To take this concentration-composition dependence 
into consideration we adjusted the compositional satura-
tion index for concentration (CH2:CH3adj), and this marker 
was able to distinguish between athletes and LD subjects in 
both muscles. The strong inverse relation of CH2:CH3adj 
with VO2max indicates that fitness is associated with a rela-
tively lower saturation of IMCLs, although overall athletes 
and controls were not statistically different; this is similar to 
results from a biopsy study (29) that demonstrated a com-
parable percentage of saturated intramuscular triglycer-
ides in male controls and athletes. Interestingly, previous 
Fig. 2. Representative 1H MRS spectra from LD sub-
jects and an athlete. Water-suppressed spectra from 
the SOL muscle of a subject with AGLD (upper left) 
and FPLD3 (upper right); the absence of EMCLs in 
AGLD is highlighted by the vertical arrow. Spectra 
from an athlete’s SOL (lower left) and TA (lower 
right) muscles illustrate the raw data (solid black) and 
overall fit (red dashed) and individual fit components 
(solid blue) in the frequency range that contains the 
EMCL CH2 (1.5 ppm), CH3 (1.1 ppm), IMCL CH2 
(1.3 ppm), and CH3 (0.9 ppm) resonances. The hori-
zontal arrows indicate that the EMCL resonances are 
systematically shifted very slightly upfield in the SOL 
muscle compared with the TA due to fiber-orientation 
effects. The CH3 resonant frequencies are linked to 
the CH2 frequencies (solid bridge lines above spectra) 
and are also shifted. The fitting procedure fixes the 
relative CH2 to the CH3 frequency shift for both 
EMCLs and IMCLs and the CH3 line width relative to 
the corresponding CH2 line width but permits soft 
constraints on the CH2 frequencies.
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Fig. 3. Composition-independent concentrations of IMCLs in LD subjects (green), controls (blue), and athletes (red). A, B: Box and 
whisker plots showing SOL and TA composition-independent IMCL concentration from the 1H MRS of methyl protons, as assessed by 
ANOVA and Games-Howell post hoc analyses. C, D: The relationship of SOL and TA composition-independent IMCL concentration with 
VO2max in a subset of participants who underwent VO2max testing, as assessed by Pearson’s correlation coefficient (controls: blue circles, 
n = 24; athletes: red triangles, n = 14). This was only significant when controls and athletes were combined (SOL: r = 0.52, P = 0.001; TA: 
r = 0.42, P = 0.009). E, F: SOL and TA IMCL CH2 and CH3 components. The values are expressed relative to the calculated water signal 
(water-calc), as described in Materials and Methods. The dotted line represents the linear regression line of the control data points. *P < 0.05, 
**P < 0.01, and ***P < 0.001.
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Fig. 4. 1H MRS measures of IMCL composition in LD subjects (green), controls (blue), and athletes (red). 
A, B: Box and whisker plots of (A) SOL and (B) TA IMCL compositional saturation index (CH2:CH3 ratio), as 
assessed by ANOVA and Games-Howell post hoc analyses. C, D: SOL and TA IMCL compositional saturation 
index adjusted for quantity. E, F: Relation of SOL and TA IMCL compositional adjusted saturation index with 
VO2max in the subset of participants who underwent VO2max testing, as assessed by Pearson’s correlation coef-
ficient (controls: blue circles, n = 24; athletes: red triangles, n = 14). There was a significant correlation in the 
SOL (r = 0.546, P = 0.006) and TA (r = 0.453, P = 0.026) for controls alone, in the SOL (r = 0.558, P = 
0.038) for athletes alone, and in the SOL (r = 0.520, P = 0.001) and TA (r = 0.362, P = 0.025) for controls 
and athletes combined. G, H: Relation of HOMA-IR with SOL and TA IMCL compositional adjusted satura-
tion index. Correlation coefficients are shown in Table 2. *P < 0.05, **P < 0.01, and ***P < 0.001.
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reports of intramuscular triglyceride composition in insu-
lin-resistant states (30, 31) yielded no difference in satura-
tion percentage but did reveal a difference in linoleate 
(31). In these studies, the intramuscular triglyceride con-
tent was higher in insulin-resistant states; therefore, a 
higher saturation percentage may not be apparent given 
the composition-concentration relation we found. This 
lack of a difference in saturation could also equally be ex-
plained by the difference in sampling intramuscular versus 
intramyocellular pools, as EMCLs generally make up a sig-
nificant proportion of intramuscular triglycerides (approx-
imately twice the IMCL pool in our healthy cohorts even 
when voxels were placed to avoid visible marbling on 
T1-weighted images; Table 1).
By our measure of composition-independent IMCLs (us-
ing the CH3 instead of the uncorrected CH2 resonance), 
we found that the LD subjects’ IMCL concentration was 
not significantly higher in either muscle compared with 
age-, gender-, and BMI-matched controls but was higher in 
the SOL relative to athletes. There are few reports of 
IMCLs in LD subjects, but our findings are in agreement with 
Peterson et al. (32), who in three subjects with generalized 
lipodystrophy (two congenital and one acquired) found 
SOL IMCL concentrations that were similar to six age-, 
BMI-, and weight-matched controls. Calf IMCL concentra-
tion was also lower in a case report of acquired generalized 
lipodystrophy (33) compared with controls, while a study 
of four subjects with congenital generalized lipodystrophy 
suggested that IMCL concentration was higher (24). Using 
the CH2 resonance, as has been conventional in previous 
studies, we found SOL IMCL content to be significantly 
higher in our LD subjects compared with controls (Table 1), 
demonstrating, we argue, the influence of composition on 
measures of concentration.
The athlete’s paradox
We found that the athletes’ IMCL concentration was sig-
nificantly lower (SOL) or similar (TA) to controls. Al-
though this seems to contradict well-known reports of an 
athlete’s paradox using both biopsy methods (13, 29, 34–
36) and 1H MRS (37, 38), this finding is in agreement with 
studies that reported no such paradox compared with old 
or young controls (39), obese individuals (40), or in cer-
tain fiber types (14). It is known that athletes can have a 
large depletion-repletion range of IMCLs, and it is possible 
that the IMCL concentration had not fully recovered since 
the last training session (24–48 h prior), as IMCLs can still 
increase significantly after these intervals (41). In fact, our 
results demonstrate an inverse relation of IMCL content 
and VO2max that is consistent with a study by Boesch et al. 
(42), in which a combination of daily training at 60% of the 
VO2 peak with a low-fat (10% to 15% fat) diet depleted 
IMCL levels in both the vastus lateralis and TA muscles to a 
consistent level that correlated with the VO2 peak, suggest-
ing that our elite female athletes were nearly “empty” of 
IMCLs; we did not control for diet in our study.
Relationship of whole-body insulin resistance to IMCLs
Within the controls, only the compositional saturation 
index adjusted for quantity (CH2:CH3adj) in the SOL was 
significantly correlated with whole-body insulin resistance 
(Table 2). The inclusion of insulin-resistant LD subjects 
increases the statistical significance of this relation and 
yields associations with other composition-influenced 
markers, but not IMCL concentration, in either muscle. In 
our study, the addition of athletes predictively reduced the 
associations with composition, as their pools were small 
and therefore had a tendency for a higher saturation in-
dex, but relations remained with measures that reflect 
large saturated pools (i.e., CH2:CH3adj and CH2). These 
striking results suggest that the accumulation of saturated 
IMCLs and not concentration alone relates to early-stage 
insulin resistance.
Supporting our findings, the concentration of the most 
abundant saturated fat, palmitic acid, within muscle triglycer-
ides has been shown to be related to insulin sensitivity (43). 
Palmitic acid is known to increase ceramide concentrations, 
which are thought to engage stress-responsive serine 
kinases that impede insulin activation of its cell-surface recep-
tor, as well as downstream signaling molecules such as insulin 
receptor substrate 1 and protein kinase B/Akt (44). Our 
study was of course not able to probe these mechanisms.
TABLE 2. Correlation coefficients of whole-body insulin resistance with IMCLs
IMCL Measure
HOMA-IR
Controls (n = 38)
Controls and  
Athletes (n = 52)
Controls and LD 
Subjects (n = 54)a 
Controls, LD Subjects, 
and Athletes (n = 68)b
SOL
 Concentration (CH3) 0.016 0.248 0.149 0.312*
 Concentration and composition (CH2) 0.153 0.315* 0.394** 0.477***
 Composition (CH2:CH3) 0.217 0.048 0.439*** 0.241*
 Composition adjusted for quantity 
(CH2:CH3adj)
0.320* 0.271* 0.583*** 0.532***
TA
 Concentration (CH3) 0.200 0.251 0.205 0.258*
 Concentration and composition (CH2) 0.224 0.247 0.338* 0.344**
 Composition (CH2:CH3) 0.100 0.046 0.337* 0.202
 Composition adjusted for quantity 
(CH2:CH3adj)
0.218 0.127 0.445*** 0.364**
*P < 0.05, **P < 0.01, and ***P  0.001.
an= 50 for TA.
bn = 64 for TA.
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Limitations
Unlike previous 1H MRS studies that have conventionally 
reported IMCL concentrations using the predominant CH2 
resonance while assuming a notional normal composition, 
here we utilized the smaller CH3 resonance, which has the 
advantage of composition independence and, with compre-
hensive prior-knowledge constraints, including line-width 
constraints relative to the CH2 resonance (22), fitted the 
IMCL CH3 resonance from the overlapping EMCL/IMCL 
CH3 signals. Due to fiber-orientation differences between 
the SOL and TA muscles, the EMCL resonances are very 
slightly systematically shifted between muscle groups. De-
spite this potential for a systematic difference in the 
CH2:CH3 ratio between muscles, this ratio was still higher in 
the SOL compared with the TA muscle in both EMCL-
deficient AGLD subjects, consistent with findings in our 
other participants in this study and a previous study (17) 
suggesting a compositional difference between muscles. 
Our LD subjects, who mainly had partial forms of lipodys-
trophy, had overall similar quantities of EMCLs to those of 
our controls and athletes that has helped to reduce poten-
tial intergroup influence of this overlapping resonance. In 
addition, the relations of IMCLs with HOMA-IR were robust 
to differing fitting routines, including constraining the 
EMCL CH3 amplitude and accounting for asymmetric line 
shapes. These findings, together with the finding that nei-
ther the IMCL CH2:CH3 nor IMCL CH2:CH3adj markers re-
lated to either EMCL CH2 or CH3, suggests a lack of EMCL 
influence in our data sets; however, it is possible that in 
other insulin-resistant cohorts large overlapping EMCL res-
onances may be a confounding factor.
Summary
The use of our recently validated and potentially widely 
applicable 1H MRS approach to determine both the IMCL 
composition and concentration independent of composi-
tion within the SOL and TA muscles of female individuals 
covering a wide range of insulin sensitivities has revealed 
that markers of the accumulation of saturated triglycerides 
in the IMCL pool are more strongly associated with whole-
body insulin resistance than IMCL concentration alone. 
Differences in associations of insulin resistance with IMCL 
concentration when using the CH3 and conventional CH2 
peaks for quantification highlights the need for awareness 
of the potential influence of composition on previously re-
ported 1H MRS measures of concentration.
Our finding of a strong relationship between VO2max and 
relatively unsaturated IMCL pools in controls and athletes 
points to a role of exercise in decreasing the amount of 
saturated fat within the IMCL store. The association of in-
sulin resistance with the accumulation of saturated IMCLs, 
even within a healthy control population, could suggest an 
early involvement in its pathogenesis and provide a reason 
why combined exercise and diet are effective therapeutic 
options in the early stages of insulin resistance.
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